INOVIO Announces Pricing of $20.0 Million Public Offering

Stock Information for Inovio Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Inovio Pharmaceuticals Inc.

INOVIO Announces Proposed Public Offering
Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm
INOVIO to Participate in Upcoming Scientific and Investor Conferences
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
INOVIO to Participate in Upcoming Scientific Conferences
INOVIO to Report First Quarter Financial Results on May 13, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.